Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Chiellino, Silvia"" wg kryterium: Autor


Wyświetlanie 1-20 z 20
Tytuł :
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
Autorzy :
Ciliberto D; a Department of Experimental and Clinical Medicine ; Magna Græcia University ; Campus Salvatore Venuta ; Catanzaro , Italy.
Staropoli N
Caglioti F
Gualtieri S
Fiorillo L
Chiellino S
De Angelis AM
Mendicino F
Botta C
Caraglia M
Tassone P
Tagliaferri P
Pokaż więcej
Źródło :
Cancer biology & therapy [Cancer Biol Ther] 2015; Vol. 16 (8), pp. 1148-59. Date of Electronic Publication: 2015 Jun 10.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Molecular Targeted Therapy/*methods
Stomach Neoplasms/*drug therapy
Angiogenesis Inhibitors/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; ErbB Receptors/antagonists & inhibitors ; Humans ; Randomized Controlled Trials as Topic ; Receptor, ErbB-2/antagonists & inhibitors ; Stomach Neoplasms/epidemiology ; Stomach Neoplasms/mortality ; Survival Analysis
Czasopismo naukowe
Tytuł :
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
Autorzy :
Ciliberto, Domenico
Staropoli, Nicoletta
Caglioti, Francesca
Gualtieri, Simona
Fiorillo, Lucia
Chiellino, Silvia
De Angelis, Antonina Maria
Mendicino, Francesco
Botta, Cirino
Caraglia, Michele
Tassone, Pierfrancesco
Tagliaferri, Pierosandro
Pokaż więcej
Źródło :
Cancer Biology and Therapy; August 2015, Vol. 16 Issue: 8 p1148-1159, 12p
Periodyk
Tytuł :
Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer.
Autorzy :
Ciliberto D; Medical Oncology and Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Graecia University, AOU Materdomini Catanzaro, CampusSalvatore Venuta, Catanzaro 88100, Italy.
Staropoli N; Medical Oncology and Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Graecia University, AOU Materdomini Catanzaro, CampusSalvatore Venuta, Catanzaro 88100, Italy.
Chiellino S; Medical Oncology and Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Graecia University, AOU Materdomini Catanzaro, CampusSalvatore Venuta, Catanzaro 88100, Italy.
Botta C; Medical Oncology and Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Graecia University, AOU Materdomini Catanzaro, CampusSalvatore Venuta, Catanzaro 88100, Italy.
Tassone P; Medical Oncology and Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Graecia University, AOU Materdomini Catanzaro, CampusSalvatore Venuta, Catanzaro 88100, Italy.
Tagliaferri P; Medical Oncology and Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Graecia University, AOU Materdomini Catanzaro, CampusSalvatore Venuta, Catanzaro 88100, Italy. Electronic address: .
Pokaż więcej
Źródło :
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] [Pancreatology] 2016 Mar-Apr; Vol. 16 (2), pp. 249-58. Date of Electronic Publication: 2016 Jan 20.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Pancreatic Neoplasms/*drug therapy
Antineoplastic Combined Chemotherapy Protocols ; Genetic Predisposition to Disease ; Humans ; Pancreatic Neoplasms/genetics ; Signal Transduction/drug effects
Czasopismo naukowe
Tytuł :
ASSURE vs. S-TRAC: conflicting results of adjuvant treatments for kidney cancer in the era of targeted agents and genomics.
Autorzy :
Porta C; Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy; ; Italian Group of Onco-Nephrology (Gruppo Italiano di Oncologia Nefrologica/GION), Pavia, Italy.
Chiellino S; Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy.
Pokaż więcej
Źródło :
Annals of translational medicine [Ann Transl Med] 2016 Oct; Vol. 4 (Suppl 1), pp. S14.
Typ publikacji :
Editorial; Comment
Opinia redakcyjna
Tytuł :
The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis.
Autorzy :
Ciliberto D; Medical Oncology, Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy.
Staropoli N; Medical Oncology, Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy.
Caglioti F; Medical Oncology, Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy.
Chiellino S; Medical Oncology, Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy.
Ierardi A; Medical Oncology, Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy.
Ingargiola R; Medical Oncology, Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy.
Botta C; Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy.
Arbitrio M; ISN-CNR, Roccelletta di Borgia, Catanzaro, Italy.
Correale P; Medical Oncology Unit, Azienda Ospedaliera 'Bianchi Melacrino Morelli', Reggio Calabria; Italy, Italy.
Tassone P; Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy.
Tagliaferri P; Medical Oncology, Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy. Electronic address: .
Pokaż więcej
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2018 May; Vol. 125, pp. 69-77. Date of Electronic Publication: 2018 Mar 09.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Colorectal Neoplasms/*pathology
Colorectal Neoplasms/*therapy
Genes, ras/*physiology
Neoadjuvant Therapy/*methods
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bayes Theorem ; Colorectal Neoplasms/genetics ; Disease-Free Survival ; Humans ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł :
Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma.
Autorzy :
Mantovani S; Division of Infectious Diseases and Immunology, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Oliviero B; Division of Infectious Diseases and Immunology, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Lombardi A; Department of Internal Medicine and Therapeutics, University of Pavia, Italy.; Division of Clinical Pathology, University Hospitals, Geneva, Switzerland.
Varchetta S; Division of Infectious Diseases and Immunology, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Mele D; Division of Infectious Diseases and Immunology, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Sangiovanni A; CRC 'A. M. and A. Migliavacca' Center for Liver Disease, Division of Gastroenterology and Hepatology.
Rossi G; Liver Transplant Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Donadon M; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.
Torzilli G; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.
Soldani C; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.
Porta C; Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Pedrazzoli P; Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Chiellino S; Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Santambrogio R; Division of Gastrointestinal Surgery, San Paolo Hospital, University of Milan School of Medicine, Milan, Italy.
Opocher E; Division of Gastrointestinal Surgery, San Paolo Hospital, University of Milan School of Medicine, Milan, Italy.
Maestri M; Department of General Surgery, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Bernuzzi S; Immunohematological and Transfusional Service and Centre of Transplantation Immunology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Rossello A; Department of Pharmacy, University of Pisa, Italy.
Clément S; Division of Clinical Pathology, University Hospitals, Geneva, Switzerland.
De Vito C; Division of Clinical Pathology, University Hospitals, Geneva, Switzerland.
Rubbia-Brandt L; Division of Clinical Pathology, University Hospitals, Geneva, Switzerland.
Negro F; Division of Clinical Pathology, University Hospitals, Geneva, Switzerland.; Division of Gastroenterology and Hepatology, University Hospitals, Geneva, Switzerland.
Mondelli MU; Division of Infectious Diseases and Immunology, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2019 Mar; Vol. 69 (3), pp. 1165-1179. Date of Electronic Publication: 2019 Feb 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular/*immunology
Killer Cells, Natural/*metabolism
Liver Neoplasms/*immunology
Natural Cytotoxicity Triggering Receptor 3/*immunology
Humans ; Natural Cytotoxicity Triggering Receptor 3/biosynthesis ; Natural Cytotoxicity Triggering Receptor 3/deficiency ; Protein Isoforms ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma.
Autorzy :
Mantovani S; Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Varchetta S; Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Mele D; Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Donadon M; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, 20089 Rozzano, Italy.
Torzilli G; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, 20089 Rozzano, Italy.
Soldani C; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, 20089 Rozzano, Italy.
Franceschini B; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, 20089 Rozzano, Italy.
Porta C; Department of Medical Sciences and Human Oncology, 'Aldo Moro' University of Bari and Policlinico Consorziale, 70124 Bari, Italy.
Chiellino S; Division of Medical Oncology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Pedrazzoli P; Division of Medical Oncology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Santambrogio R; Division of General Surgery, ASST Fatebenefratelli-Sacco, 20131 Milan, Italy.
Barabino M; Division of Gastrointestinal Surgery, ASST Santi Paolo e Carlo, and State University of Milan, 20142 Milan, Italy.
Cigala C; Division of Gastrointestinal Surgery, ASST Santi Paolo e Carlo, and State University of Milan, 20142 Milan, Italy.
Piccolo G; Division of Gastrointestinal Surgery, ASST Santi Paolo e Carlo, and State University of Milan, 20142 Milan, Italy.
Opocher E; Division of Gastrointestinal Surgery, ASST Santi Paolo e Carlo, and State University of Milan, 20142 Milan, Italy.
Maestri M; Division of General Surgery, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Sangiovanni A; Division of Gastroenterology and Hepatology, CRC 'A. M. and A. Migliavacca' Center for Liver Disease, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Bernuzzi S; Immunohematology and Transfusion Service, Centre of Transplantation Immunology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Lhospice F; Innate Pharma, 13009 Marseille, France.
Kraiem M; Innate Pharma, 13009 Marseille, France.
Mondelli MU; Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.; Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
Oliviero B; Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2020 Nov 30; Vol. 12 (12). Date of Electronic Publication: 2020 Nov 30.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons?
Autorzy :
Lasagna A; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, Italy.
Zuccaro V; Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, Italy.
Sacchi P; Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, Italy.
Chiellino S; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, Italy.
Bruno R; Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, Italy.; Department of Clinical, Surgical, Diagnostic & Pediatric Sciences, University of Pavia, Viale Camillo Golgi 19, Pavia, Italy.
Pedrazzoli P; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, Italy.; Department of Internal Medicine & Medical Therapy, University of Pavia, Viale Camillo Golgi 19, Pavia, Italy.
Pokaż więcej
Źródło :
Future oncology (London, England) [Future Oncol] 2021 May; Vol. 17 (13), pp. 1577-1580. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
Autorzy :
Rebuzzi SE; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino of Genova, Largo Rosanna Benzi 10, Genova, 16132, Italy.
Signori A; Department of Health Sciences, Section of Biostatistics, University of Genova, Genova, Italy.
Banna GL; Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK Cannizzaro Hospital, Catania, Italy.
Maruzzo M; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Pedrazzoli P; Medical Oncology Unit, IRCCS Policlinico San Matteo, Pavia, Italy.
Sbrana A; Medical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Zucali PA; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milano, Italy.
Masini C; Medical Oncology Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
Naglieri E; Division of Medical Oncology, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Procopio G; SS Oncologia Medica Genitourinaria, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Merler S; Department of Oncology, Azienda Ospedaliera Universitaria Integrata di Verona, University of Verona,Verona, Italy.
Tomasello L; Academic Unit of Medical Oncology, IRCCS Ospedale Policlinico San Martino of Genova, Genova, Italy.
Fratino L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano CRO-IRCCS, Aviano, Italy.
Baldessari C; Medical Oncology Unit, Department of Oncology and Hemathology, University Hospital of Modena, Modena, Italy.
Ricotta R; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Panni S; Medical Oncology Unit, ASST - Istituti Ospitalieri Cremona Hospital, Cremona, Italy.
Mollica V; Oncologia Medica, Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.
Sorarù M; U.O. Oncologia, Ospedale di Camposampiero, Italy.
Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy.
Cortellini A; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Prati V; Medical Oncology Unit, ASL CN 2, Alba-Bra, Italy.
Soto Parra HJ; Department of Oncology, Medical Oncology, University Hospital Policlinico-San Marco, Catania, Italy.
Stellato M; Department of Medical Oncology, Università Campus Bio-Medico of Roma, Rome, Italy.
Atzori F; Medical Oncology Department, University Hospital, University of Cagliari, Cagliari, Italy.
Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.
Messina C; Medical Oncology Department, Santa Chiara Hospital, Trento, Italy.
Messina M; UOC Oncologia Medica, Istituto Fondazione G. Giglio, Cefalù, Italy.
Morelli F; Medical Oncology Department, Casa Sollievo Della Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy.
Prati G; Department of oncology and advanced technologies AUSL - IRCCS Reggio Emilia, Reggio Emilia, Italy.
Nolè F; Medical Oncology Division of Urogenital & Head & Neck Tumors, IEO, European Institute of Oncology IRCCS, Milano, Italy.
Vignani F; Division of Medical Oncology, Ordine Mauriziano Hospital, Torino, Italy.
Cavo A; Oncology Unit, Villa Scassi Hospital, Genova, Italy.
Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Firenze, Firenze, Italy.
Pierantoni F; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
Casadei C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Bersanelli M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
Chiellino S; Medical Oncology Unit, IRCCS Policlinico San Matteo, Pavia, Italy.
Paolieri F; Medical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Perrino M; Department of Oncology, IRCCS, Humanitas Clinical and Research Center, Rozzano, Milano, Italy.
Brunelli M; Department of Diagnostics and Public Health, Pathology Unit, University and Hospital Trust of Verona, Verona, Italy.
Iacovelli R; Medical Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Porta C; Chair of Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari 'A. Moro', Bari, Italy.
Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino of Genova, Genova, Italy.
Pokaż więcej
Źródło :
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2021 May 18; Vol. 13, pp. 17588359211019642. Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-20 z 20

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies